Stock Screener App

Frei -

Installieren

4.30

1.83% -0.08

Fortress Biotech Inc (FBIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt FBIO? Forum Prognose Aktiensplit

Fortress Biotech Inc Aktie (FBIO) Neueste Nachrichten

Fortress Biotech (NASDAQ:FBIOP) Shares Up 2.4% – Should You Buy? - Defense World

Will Fortress Biotech Inc.(CNB0) stock rise with strong economyMarket Sentiment Summary & Risk Managed Investment Signals - ulpravda.ru

Fortress Biotech (NASDAQ:FBIO) Stock Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World

Aug Rallies: Can Fortress Biotech Inc. stock hit record highs againBond Market & AI Optimized Trade Strategies - ulpravda.ru

Will Fortress Biotech Inc. stock benefit from AI adoptionOptions Play & Short-Term Trading Alerts - ulpravda.ru

Can Fortress Biotech Inc. stock hit record highs againMarket Movement Recap & Daily Profit Maximizing Tips - ulpravda.ru

How Fortress Biotech Inc. stock compares to industry benchmarksJobs Report & Real-Time Buy Signal Alerts - ulpravda.ru

Will Fortress Biotech Inc. stock outperform international peersJuly 2025 Review & Expert Verified Stock Movement Alerts - ulpravda.ru

Is Fortress Biotech Inc.(CNB0) stock testing key supportWeekly Investment Report & Stepwise Entry/Exit Trade Alerts - ulpravda.ru

Fortress Biotech amends credit agreement with Oaktree - MSN

Fortress Biotech (NASDAQ: FBIO) reports 13.4% Avenue (ATXI) stake with voting control - Stock Titan

FBIO Stock Price, Forecast & Analysis | FORTRESS BIOTECH INC (NASDAQ:FBIO) - Chartmill

Head-To-Head Comparison: Fortress Biotech (NASDAQ:FBIO) & WAVE Life Sciences (NASDAQ:WVE) - Defense World

Journey Medical Corporation Announces Positive Topline Results from its Two Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 for the Treatment of Papulopustular Rosacea in Adults - ADVFN

Fortress Biotech (NASDAQ:FBIO) Stock Price Passes Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat

How Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) Affects Rotational Strategy Timing - Stock Traders Daily

Signal Recap: Will Fortress Biotech Inc stock benefit from AI adoptionMarket Sentiment Report & Consistent Profit Trading Strategies - moha.gov.vn

Fortress Biotech (NASDAQ:FBIO) Stock Price Passes Above 200-Day Moving AverageHere's What Happened - MarketBeat

What analysts say about Fortress Biotech Inc stockEx-Dividend Date Alerts & High Yield Portfolio Growth - earlytimes.in

(FBIOP) Risk Channels and Responsive Allocation - Stock Traders Daily

Investors Still Aren't Entirely Convinced By Fortress Biotech, Inc.'s (NASDAQ:FBIO) Revenues Despite 28% Price Jump - 富途牛牛

Is Fortress Biotech Inc.(CNB0) stock resilient in recession scenarios2025 Market WrapUp & AI Powered Market Trend Analysis - Улправда

Fortress Biotech (NASDAQ: FBIO) registers 600,000 shares for Oaktree resale - Stock Titan

What momentum indicators show for Fortress Biotech Inc. stockJuly 2025 Big Picture & Weekly Setup with High ROI Potential - Улправда

Triplex vaccine enters Phase 2 trial in stem cell donors - MSN

Fortress Biotech’s CUTX-101 NDA resubmission accepted by FDA - MSN

Fortress Biotech (FBIO) files for 600K share offering by selling stockholders - StreetInsider

Investors Still Aren't Entirely Convinced By Fortress Biotech, Inc.'s (NASDAQ:FBIO) Revenues Despite 27% Price Jump - simplywall.st

Fortress Biotech (NASDAQ:FBIO) Shares Pass Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Fortress Biotech (NASDAQ:FBIO) Shares Pass Above Two Hundred Day Moving Average – Time to Sell? - Defense World

Fortress Biotech (Nasdaq: FBIO) resale filing covers 600,000 shares for Oaktree - Stock Titan

Fortress Biotech Amends Credit Agreement with Oaktree - TipRanks

ATXI SEC FilingsAvenue Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Fortress Biotech (NASDAQ: FBIO) extends loan maturity and grants warrants - Stock Titan

Fortress Biotech, Inc. Enters into First Amendment to Credit Agreement - marketscreener.com

Fortress Biotech, Inc. and Cyprium Therapeutics, Inc. Announce FDA Acceptance of CUTX-101 NDA Resubmission - marketscreener.com

FDA sets new PDUFA date for Fortress Biotech’s Menkes disease therapy - Investing.com Nigeria

Fortress Biotech Rises After FDA Accepts Application for Menkes Treatment - marketscreener.com

Fortress Biotech, Cyprium announce FDA acceptance of CUTX-101 NDA resubmission - TipRanks

Fortress Biotech, Cyprium get FDA acceptance for CUTX-101 NDA resubmission - marketscreener.com

Fortress Biotech, Cyprium Get FDA Acceptance for CUTX-101 NDA Resubmission - TradingView — Track All Markets

Fortress Biotech’s CUTX-101 NDA Resubmission Accepted by FDA - TipRanks

Fortress Biotech (FBIO) Resubmits Application for Menkes Disease Treatment - GuruFocus

Fortress Biotech Announces FDA Acceptance of CUTX-101 NDA Resubmission - TradingView — Track All Markets

[8-K] Fortress Biotech, Inc. Reports Material Event | FBIO SEC FilingForm 8-K - Stock Titan

Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission - GlobeNewswire

Fortress Biotech, Inc. (NASDAQ:FBIO) Q3 2025 Earnings Call Transcript - MSN

Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology - GlobeNewswire

(FBIOP) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Published on: 2025-12-08 06:59:10 - moha.gov.vn

FBIOP | Fortress Biotech, Inc. 9.375% Stock Data, Price & News - Quiver Quantitative

Fortress Biotech (NASDAQ:FBIO) Share Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat

Fortress Biotech (NASDAQ:FBIO) Share Price Passes Above 200 Day Moving Average – Time to Sell? - Defense World

Avenue Therapeutics (NASDAQ: ATXI) 2025 proxy on director elections, KPMG audit and Fortress control - Stock Titan

Is Fortress Biotech Inc.(CNB0) stock undervalued historicallyWeekly Trading Summary & Pattern Based Trade Signal System - Newser

INCY

$106.87

0.90%

GMAB

$34.26

1.87%

RVMD

$118.64

10.48%

BNTX

$99.85

1.01%

ONC

$337.89

5.47%

INSM

$175.97

3.35%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters